This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Daria Donati
Global Director for Business Development and Innovation at Cytiva, formerly GE Healthcare Life Sciences


Daria Donati is currently focused on driving innovation and bringing forward-looking technology into the everyday lives of Cytiva's customers and employees. To that end, she oversees global collaborations, alliances and technology intake. Daria’s roots are in academia and public health. She has worked with the MIM-TDR (WHO) supporting capacity building in sub-Saharan Africa as International Liaison manager, leading global collaborations and funding management to support sustainable development projects in healthcare. In the business sector, she has over 20 years of diverse management and technology solution experience within biotech and biomanufacturing. She first joined Cytiva, formerly GE Healthcare in 2008, and has been in her current role in the Chief Technology Office since 2018. She has led key endeavors within vaccine manufacturing solutions and biomanufacturing within Enterprise solutions, which develops and delivers biopharma manufacturing solutions, providing the tools and services to enable speed to market and rapid response, increasing the access to life-saving drugs.

Daria was instrumental in driving the development and commercialization of the remarkable KUBio, the first off-the-shelf biomanufacturing facility in the industry, now used by four global customers, enabling production of precision medicines in 13 countries. Daria is a sought-after speaker at industry and alliance events. In 2017 Daria was named European Businesswoman of the Year 2017 in the category Life Sciences. Her engagement in public health and development of medicines against infectious diseases has brought her to live and work in more than five countries in Africa, Europe and North America. She served as principal investigator working on malaria, infectious diseases, immunology and vaccines at Karolinka Institute in Sweden, from which she earned one PhD in Experimental Medicine. Her second PhD is in Biotechnology and Transplant Immunology from The University of Pisa, Italy, and a Master in Science, with major in Molecular Biology from the University of Pisa, Italy